pioglitazone and glimepiride

Prasco Laboratories🇺🇸 United States

FDA Page

Effective Date: Dec 16, 2021
Approval ID: ea385b3d-cb4c-4550-97b0-93a86533f6dc
Products: 2 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use pioglitazone and glimepiride tablets safely and effectively. See full prescribing information for pioglitazone and glimepiride tablets. Pioglitazone and Glimepiride Tablets, for oral use Initial U.S. Approval: 2006

Quick Stats

Total Products2

Labelers2

Label Sections40

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.